Search

Copyright of Neurocirugía is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

A recent report from the University of California San Diego (UCSD) discusses the integration of augmented reality (AR) technology into endoscopic third ventriculostomy (ETV) procedures. ETV is a minimally invasive technique used to treat hydrocephalus by creating a new pathway for cerebrospinal fluid drainage in the brain's ventricular system. The use of AR in ETV procedures aims to enhance surgical visualization, navigation, and decision-making, potentially leading to improved patient outcomes. This research has been peer-reviewed and offers insights into the potential benefits of AR technology in neurosurgery. [Extracted from the article]

A recent study conducted by researchers at New York University (NYU) Langone Health examined the role of early postoperative magnetic resonance imaging (MRI) in predicting the success of endoscopic third ventriculostomy (ETV) as a treatment for obstructive hydrocephalus. The study found that no single imaging parameter could predict the success of ETV, but the absence of a flow void was associated with ETV failure. However, the researchers concluded that immediate postoperative imaging has limited influence on clinical management. The study highlights the need for further research to determine the true negative predictive value of the absence of a flow void. [Extracted from the article]

Copyright of Neurocirugía is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

A study conducted by Shiraz University of Medical Sciences investigated the factors that impact the success of endoscopic third ventriculostomy (ETV) in pediatric patients with hydrocephalus. The study found that a smaller maximum diameter of the cortical subarachnoid space (CSAS) was associated with ETV failure at 6 months, while a lower pulsatility index (PI) was associated with ETV failure at 1 year. These findings suggest that considering specific factors such as CSAS and PI can help predict the likelihood of ETV success and improve outcomes for pediatric patients with hydrocephalus. Further research is needed to optimize patient selection for ETV treatment. [Extracted from the article]

A recent study conducted at Seoul National University focused on the challenges of performing endoscopic third ventriculostomy (ETV) in patients with achondroplasia, a form of dwarfism. The researchers analyzed the anatomical variations of the third ventricle and the brainstem in achondroplasia patients and compared them to patients without achondroplasia. They found that achondroplasia patients had steeper third ventricle floors and basilar arteries located closer to the dorsum sellae, which made ETV more difficult to perform. These anatomical differences should be taken into consideration when planning ETV for achondroplasia patients. [Extracted from the article]

A new report discusses research findings on central nervous system disorders, specifically focusing on the co-infection of human herpesvirus 6 (HHV-6) and tuberculosis (TB). The report presents a case study of an 18-month-old female patient who exhibited symptoms of meningitis and hydrocephalus. The patient's condition improved with the initiation of antiviral therapy, highlighting the importance of considering HHV-6 as a potential pathogen in central nervous system infections. The report aims to inform neurosurgeons about the clinical significance of HHV-6 in these cases. [Extracted from the article]

A recent study conducted by researchers at the University of Southern Florida examined the use of endoscopic third ventriculostomy (ETV) as a treatment for concurrent Chiari Malformation Type I (CMI) and hydrocephalus in adults. The study analyzed 11 articles that met inclusion criteria and found that ETV provided a pooled rate of symptom resolution or improvement of 66%. Additionally, ETV was found to improve radiological outcomes such as ventriculomegaly and tonsillar descent, as well as alleviate headaches. The study concluded that ETV is a safe and effective treatment option for managing acquired CMI with hydrocephalus. [Extracted from the article]

A recent study conducted at the Federal University Minas Gerais in Brazil examined the success factors of endoscopic third ventriculostomy (ETV) in patients with hydrocephalus and myelomeningocele (MMC). The study found that age was a significant factor affecting the success of ETV, with younger patients having lower success rates. However, radiological factors did not have a significant impact on ETV outcomes. The researchers concluded that identifying predictors of ETV success in MMC patients is important for improving treatment strategies and patient outcomes. [Extracted from the article]

A recent study conducted by researchers at New York University (NYU) analyzed the literature on endoscopic third ventriculostomy (ETV) using bibliometric analysis. The study found that the number of publications on ETV has been steadily increasing, with a mean annual growth rate of 4.9%. International coauthorship and female and minority authorship have also increased over time. The focus of research has shifted from etiology to outcomes, complication management, and technical mastery. The study identified the most prolific authors on the subject and highlighted key articles that have laid the foundation for ETV research. [Extracted from the article]

A recent study conducted by researchers at the University of Miami Miller School of Medicine has examined the feasibility and safety of same-day discharge for patients undergoing intracranial tumor resection and endoscopic third ventriculostomy (ETV). The study included 202 patients, with a mean age of 56.8 years, and found that 88.6% of patients were successfully discharged on the same day of surgery. Complications occurred in 1.5% of patients, and there were no permanent complications observed during the follow-up period. The study concludes that same-day discharge is safe and feasible, and emphasizes the importance of clear discharge protocols and patient education for successful implementation of same-day discharge programs in neurosurgery. [Extracted from the article]

A recent study compared the outcomes of two different treatments for hydrocephalus in children who underwent fetal myelomeningocele repair. The study found that patients who received endoscopic third ventriculostomy with choroid plexus cauterization (ETV/CPC) had better outcomes compared to those who received a ventriculoperitoneal shunt (VPS). The ETV/CPC group had fewer complications, required fewer hospital readmissions, and had fewer imaging scans compared to the VPS group. These findings suggest that ETV/CPC may be a preferred method of cerebrospinal fluid diversion following fetal myelomeningocele repair. [Extracted from the article]

A study conducted at the University of Oklahoma Health Sciences Center examined the impact of endoscopic third ventriculostomy (ETV) failure on the subsequent risk of ventriculoperitoneal shunt (VPS) placement in pediatric hydrocephalus patients. The study found that there was no significant difference in overall complication rates between patients who received VPS following failed ETV and those who received VPS alone. However, patients who had undergone ETV had a higher rate of cerebrospinal fluid (CSF) leakage within 12 months of VPS placement. Further research is needed to determine if prior ETV procedures increase the risk of complications during VPS placement. [Extracted from the article]

A study conducted by researchers at Iran University of Medical Sciences examined the effectiveness of endoscopic third ventriculostomy (ETV) in preventing hydrocephalus and the need for shunting in patients undergoing surgery for posterior fossa tumors. The study included 40 patients, with 23 receiving preoperative ETV and 17 serving as controls. The results showed that none of the patients in the ETV group required postoperative shunting, while 7 patients in the non-ETV group did. The researchers concluded that ETV before surgical removal of posterior fossa tumors can effectively reduce the rate of postoperative hydrocephalus and the need for shunting. [Extracted from the article]

A recent study conducted at the University of Fukui in Japan examined the effectiveness of endoscopic third ventriculostomy (ETV) as a treatment for obstructive hydrocephalus in elderly patients. The study focused on the case of an 80-year-old woman with cognitive impairment and gait disturbance caused by a pineal region meningioma. The patient underwent simultaneous endoscopic tumor biopsy and ETV, which resulted in improved cognition and diminished gait disturbances. The findings of this study may contribute to the management of elderly patients with obstructive hydrocephalus, particularly in aging societies. [Extracted from the article]

A recent report from the University of Alabama Birmingham discusses the use of alternative balloons for endoscopic third ventriculostomy (ETV) in the treatment of hydrocephalus. The study explores the use of cardiac angioplasty and neurovascular balloons as substitutes for the specialized Neuroballoon, which is often unavailable during supply chain shortages. The researchers found that the scepter balloon and the Cardiac TREK balloon were effective alternatives, with the latter being easier to manage and cheaper. The study concludes that non-neuroendoscopic specialized balloons can be viable alternatives for ETV dilation. [Extracted from the article]

A recent study conducted at the University of South Florida challenges the conventional belief that ventriculoperitoneal shunting is the ideal treatment for all types of hydrocephalus. The researchers found that patients with aqueductal stenosis, a specific type of hydrocephalus, experienced symptoms of over- and underdrainage despite having a functioning shunt. However, when these patients underwent endoscopic third ventriculostomy (ETV), their hydrocephalus improved without the need for secondary cerebrospinal fluid diversion. The study suggests that ETV may be a viable treatment option for aqueductal stenosis patients, even with a patent ventriculoperitoneal shunt. [Extracted from the article]

A recent study conducted by researchers at the Department of Neurosurgery explores an alternative technique called extra-axial endoscopic third ventriculostomy (EAETV) to overcome complications associated with conventional endoscopic third ventriculostomy (ETV) in the treatment of hydrocephalus. The study included ten patients with obstructive triventricular hydrocephalus, and after undergoing EAETV, all patients showed clinical improvement. The results demonstrated that EAETV is a safe and effective surgical alternative to conventional ETV. This research provides valuable insights for medical professionals and patients seeking treatment for hydrocephalus. [Extracted from the article]

A recent study conducted by the Hydrocephalus Clinical Research Network (HCRN) aimed to evaluate the performance of the Endoscopic Third Ventriculostomy Success Score (ETVSS) in predicting the success of endoscopic third ventriculostomy (ETV) procedures for hydrocephalus. The study included 761 children who underwent a first-time ETV and found that the original ETVSS demonstrated good predictive ability for ETV success. The addition of radiological variables did not significantly improve the predictive abilities of the ETVSS. The study also suggested a possible association between preoperative prepontine adhesions and ETV success, which should be further investigated in future studies. [Extracted from the article]

A recent study conducted at Patan Hospital in Nepal compared two surgical approaches, ventriculoperitoneal shunt (VPS) and endoscopic third ventriculostomy (ETV), for managing hydrocephalus caused by tuberculous meningitis (TBM). The study enrolled 60 adult patients with TBM-related hydrocephalus and followed them for a minimum of 30 days. The results showed that both VPS and ETV were effective in managing hydrocephalus, with no discernible differences in outcomes between the two procedures. However, the researchers suggested that ETV may be considered as the primary choice for cerebrospinal fluid diversion in TBM-associated hydrocephalus due to its avoidance of lifelong complications associated with VPS. [Extracted from the article]

A new report from researchers at the Bangur Institute of Neurosciences in West Bengal, India, compares the effectiveness of two surgical treatments for hydrocephalus, a disorder characterized by the abnormal enlargement of the ventricles in the brain due to excessive accumulation of cerebrospinal fluid. The standard treatment is ventriculoperitoneal shunt (VPS), but this study suggests that endoscopic third ventriculostomy (ETV) may be a safer alternative, particularly for non-communicating hydrocephalus. The study found that ETV had a lower reoperation and complication rate compared to VPS at 4th, 12th, and 24th weeks after treatment. Aqueductal stenosis was the most common cause of hydrocephalus in both groups. [Extracted from the article]

A recent study from Al-Azhar University provides new insights into the success and challenges of endoscopic third ventriculostomy (ETV), a surgical procedure for treating obstructive hydrocephalus. The study aimed to create easily interpretable traffic light alarming signs to increase neurosurgeons' awareness of ETV difficulty and failure. The researchers developed the ETV difficulty scale (ETV-DS) as an intraoperative monitor and the ETV failure threshold (ETV-FT) for postoperative evaluation. The findings suggest that these traffic light alarming signs can help neurosurgeons recognize critical cases that require extra precautions for successful outcomes. [Extracted from the article]

Keywords: Beijing; People's Republic of China; Asia; Biomechanical Engineering; Health and Medicine; Surgery; Third Ventriculostomy; Ventriculostomy EN Beijing People's Republic of China Asia Biomechanical Engineering Health and Medicine Surgery Third Ventriculostomy Ventriculostomy 1342 1342 1 10/30/23 20231103 NES 231103 2023 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- New research on Surgery - Third Ventriculostomy is the subject of a report. It was found that a smaller diameter fiber endoscope, a perpendicular puncture angle, and a faster puncture speed would decrease the damage of brain tissue caused by the fiber endoscope.". [Extracted from the article]

According to the news editors, the research concluded: "ETV is safe and effective for children with obstructive hydrocephalus experiencing shunt dysfunction, notably in cases of primary obstructive hydrocephalus with aqueductal stenosis, and among children whose age was 36 months who had postinflammatory hydrocephalus." Keywords: Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Health and Medicine; Hydrocephalus; Intracranial Hypertension; Pediatrics; Surgery; Third Ventriculostomy; Ventriculostomy EN Brain Diseases and Conditions Central Nervous System Diseases and Conditions Health and Medicine Hydrocephalus Intracranial Hypertension Pediatrics Surgery Third Ventriculostomy Ventriculostomy 710 710 1 10/16/23 20231020 NES 231020 2023 OCT 22 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Researchers detail new data in hydrocephalus. [Extracted from the article]

Keywords: Cairo; Egypt; Africa; Angiology; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Health and Medicine; Hydrocephalus; Intracranial Hypertension; Stenosis; Surgery; Third Ventriculostomy; Ventriculostomy EN Cairo Egypt Africa Angiology Brain Diseases and Conditions Central Nervous System Diseases and Conditions Health and Medicine Hydrocephalus Intracranial Hypertension Stenosis Surgery Third Ventriculostomy Ventriculostomy 595 595 1 09/19/23 20230923 NES 230923 2023 SEP 24 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Investigators discuss new findings in Central Nervous System Diseases and Conditions - Hydrocephalus. Our news editors obtained a quote from the research from Cairo University, "A retrospective review of cases undergoing cine phase-contrast magnetic resonance imaging (PC-MRI) from 2015 to 2022 of any age with imaging evidence of arrested obstructive hydrocephalus was performed. [Extracted from the article]

Keywords: Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Health and Medicine; Hemorrhage; Hydrocephalus; Infant and Newborn Diseases and Conditions; Intracranial Hypertension; Risk and Prevention; Surgery; Third Ventriculostomy; Ventriculostomy EN Brain Diseases and Conditions Central Nervous System Diseases and Conditions Health and Medicine Hemorrhage Hydrocephalus Infant and Newborn Diseases and Conditions Intracranial Hypertension Risk and Prevention Surgery Third Ventriculostomy Ventriculostomy 203 203 1 08/14/23 20230818 NES 230818 2023 AUG 20 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- New research on hydrocephalus is the subject of a new report. Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Health and Medicine, Hemorrhage, Hydrocephalus, Infant and Newborn Diseases and Conditions, Intracranial Hypertension, Risk and Prevention, Surgery, Third Ventriculostomy, Ventriculostomy Data from San Luis Potosi Update Knowledge in Hydrocephalus (Neuroendoscopic Lavage and Third Ventriculostomy for the Treatment of Intraventricular Hemorrhage and Hydrocephalus in Neonates. [Extracted from the article]

Keywords: Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Health and Medicine; Hydrocephalus; Intracranial Hypertension; Surgery; Third Ventriculostomy; Ventriculostomy EN Brain Diseases and Conditions Central Nervous System Diseases and Conditions Health and Medicine Hydrocephalus Intracranial Hypertension Surgery Third Ventriculostomy Ventriculostomy 801 801 1 05/08/23 20230514 NES 230514 2023 MAY 14 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Researchers detail new data in hydrocephalus. Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Health and Medicine, Hydrocephalus, Intracranial Hypertension, Surgery, Third Ventriculostomy, Ventriculostomy. [Extracted from the article]

El abordaje endoscópico habitual para el manejo diagnóstico y terapéutico de los tumores pineales es a través del asta frontal del ventrículo lateral introduciendo el endoscopio por el agujero de Monro. Presentamos el caso de un paciente con esta patología en el que se realizó toma de biopsia de la lesión a través de la fisura coroidea mediante un acceso endoscópico al atrio ventricular. Paciente varón de 25 años de edad que comienza con cefalea y diplopía. Al examen físico se constata signo de Parinaud y papiledema. La resonancia magnética demostró una lesión ocupante de la región pineal asociada a hidrocefalia. Inicialmente por vía endoscópica habitual (acceso frontal) se trató la hidrocefalia y se tomó biopsia del tumor. El espécimen tisular no fue útil, por lo que se planificó un segundo procedimiento endoscópico para la toma de tejido tumoral a través de la fisura coroidea introduciendo el endoscopio a través del atrio. El abordaje a los tumores pineales a través del atrio ventricular, mediante un agujero parietal, realizando apertura de la fisura coroidea permite la toma directa de biopsia, con una trayectoria endoscópica única, sin necesidad de atravesar otras estructuras neurales. The usual endoscopic approach in the management of pineal region tumours consists of inserting the scope into the frontal horn of the lateral ventricle and advancing it through the foramen of Monro into the third ventricle. We report the case of a patient with a pineal tumour on whom we used an endoscopic approach through the ventricular atrium to obtain a biopsy by opening the choroidal fissure. This young 25-year-old man presented with headache and double vision. Papilloedema and Parinaud's syndrome were found on physical examination. Cranial magnetic resonance revealed a pineal mass and hydrocephalus. We initially performed a third ventriculostomy and a tumour biopsy through a frontal burr hole. The tissue sample was not useful for pathological diagnosis and we decided to perform a second endoscopic biopsy. The endoscopic approach to pineal region masses, reaching the ventricular atrium through a parietal burr hole and opening the choroidal fissure, makes it possible to take a biopsy using a single endoscopic approach without needing to cross other ventricular structures. [ABSTRACT FROM AUTHOR]